Industry Research Reports

Home > Reports > Medical Care > Global Mitochondrial Disease Therapeutics Market Research Report 2024

Global Mitochondrial Disease Therapeutics Market Research Report 2024

Industry: Medical Care

Published: 2024-01-21

Pages: 89 Pages

Report ld: 2766546

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Mitochondrial Disease Therapeutics market was valued at US$ 390 million in 2023 and is anticipated to reach US$ 617.3 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.

North American market for Mitochondrial Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Mitochondrial Disease Therapeutics Market Size

M= millions and B=billions

Asia-Pacific market for Mitochondrial Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Mitochondrial Disease Therapeutics in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Mitochondrial Disease Therapeutics include Santhera Pharmaceuticals, Reata Pharmaceuticals, Khondrion, Stealth BioTherapeutics, BioElectron Technology, NeuroVive Pharmaceutical, Mitobridge, Mitochon Pharmaceuticals and Mitocure, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Mitochondrial Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mitochondrial Disease Therapeutics.

Report Scope
The Mitochondrial Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mitochondrial Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mitochondrial Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Mitochondrial Disease Therapeutics Market Research Report 2024
Forecasted Market Size in 2030
US$ 617.3 million
CAGR(2024-2030)
6.8%
Market Size Available for Years
2019-2030
Global Mitochondrial Disease Therapeutics Companies Covered
Santhera Pharmaceuticals, Reata Pharmaceuticals, Khondrion, Stealth BioTherapeutics, BioElectron Technology, NeuroVive Pharmaceutical, Mitobridge, Mitochon Pharmaceuticals, Mitocure, GenSight Biologics
Global Mitochondrial Disease Therapeutics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mitochondrial Disease Therapeutics Market, Segment by Type
Anti-Inflammatory Biologics

Non-Steroidal Anti-Inflammatory Drugs

Corticosteroids
Global Mitochondrial Disease Therapeutics Market, Segment by Application
Hospital Pharmacies

Retail Pharmacies

Online Pharmacies
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mitochondrial Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Mitochondrial Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Anti-Inflammatory Biologics
        1.2.3 Non-Steroidal Anti-Inflammatory Drugs
        1.2.4 Corticosteroids
    1.3 Market by Application
        1.3.1 Global Mitochondrial Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Mitochondrial Disease Therapeutics Market Perspective (2019-2030)
    2.2 Mitochondrial Disease Therapeutics Growth Trends by Region
        2.2.1 Global Mitochondrial Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Mitochondrial Disease Therapeutics Historic Market Size by Region (2019-2024)
        2.2.3 Mitochondrial Disease Therapeutics Forecasted Market Size by Region (2025-2030)
    2.3 Mitochondrial Disease Therapeutics Market Dynamics
        2.3.1 Mitochondrial Disease Therapeutics Industry Trends
        2.3.2 Mitochondrial Disease Therapeutics Market Drivers
        2.3.3 Mitochondrial Disease Therapeutics Market Challenges
        2.3.4 Mitochondrial Disease Therapeutics Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Mitochondrial Disease Therapeutics Players by Revenue
        3.1.1 Global Top Mitochondrial Disease Therapeutics Players by Revenue (2019-2024)
        3.1.2 Global Mitochondrial Disease Therapeutics Revenue Market Share by Players (2019-2024)
    3.2 Global Mitochondrial Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Mitochondrial Disease Therapeutics Revenue
    3.4 Global Mitochondrial Disease Therapeutics Market Concentration Ratio
        3.4.1 Global Mitochondrial Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Mitochondrial Disease Therapeutics Revenue in 2023
    3.5 Mitochondrial Disease Therapeutics Key Players Head office and Area Served
    3.6 Key Players Mitochondrial Disease Therapeutics Product Solution and Service
    3.7 Date of Enter into Mitochondrial Disease Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Mitochondrial Disease Therapeutics Breakdown Data by Type
    4.1 Global Mitochondrial Disease Therapeutics Historic Market Size by Type (2019-2024)
    4.2 Global Mitochondrial Disease Therapeutics Forecasted Market Size by Type (2025-2030)

 5 Mitochondrial Disease Therapeutics Breakdown Data by Application
    5.1 Global Mitochondrial Disease Therapeutics Historic Market Size by Application (2019-2024)
    5.2 Global Mitochondrial Disease Therapeutics Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Mitochondrial Disease Therapeutics Market Size (2019-2030)
    6.2 North America Mitochondrial Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
    6.3 North America Mitochondrial Disease Therapeutics Market Size by Country (2019-2024)
    6.4 North America Mitochondrial Disease Therapeutics Market Size by Country (2025-2030)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Mitochondrial Disease Therapeutics Market Size (2019-2030)
    7.2 Europe Mitochondrial Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
    7.3 Europe Mitochondrial Disease Therapeutics Market Size by Country (2019-2024)
    7.4 Europe Mitochondrial Disease Therapeutics Market Size by Country (2025-2030)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Mitochondrial Disease Therapeutics Market Size (2019-2030)
    8.2 Asia-Pacific Mitochondrial Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
    8.3 Asia-Pacific Mitochondrial Disease Therapeutics Market Size by Region (2019-2024)
    8.4 Asia-Pacific Mitochondrial Disease Therapeutics Market Size by Region (2025-2030)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Mitochondrial Disease Therapeutics Market Size (2019-2030)
    9.2 Latin America Mitochondrial Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
    9.3 Latin America Mitochondrial Disease Therapeutics Market Size by Country (2019-2024)
    9.4 Latin America Mitochondrial Disease Therapeutics Market Size by Country (2025-2030)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Mitochondrial Disease Therapeutics Market Size (2019-2030)
    10.2 Middle East & Africa Mitochondrial Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
    10.3 Middle East & Africa Mitochondrial Disease Therapeutics Market Size by Country (2019-2024)
    10.4 Middle East & Africa Mitochondrial Disease Therapeutics Market Size by Country (2025-2030)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Santhera Pharmaceuticals
        11.1.1 Santhera Pharmaceuticals Company Detail
        11.1.2 Santhera Pharmaceuticals Business Overview
        11.1.3 Santhera Pharmaceuticals Mitochondrial Disease Therapeutics Introduction
        11.1.4 Santhera Pharmaceuticals Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.1.5 Santhera Pharmaceuticals Recent Development
    11.2 Reata Pharmaceuticals
        11.2.1 Reata Pharmaceuticals Company Detail
        11.2.2 Reata Pharmaceuticals Business Overview
        11.2.3 Reata Pharmaceuticals Mitochondrial Disease Therapeutics Introduction
        11.2.4 Reata Pharmaceuticals Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.2.5 Reata Pharmaceuticals Recent Development
    11.3 Khondrion
        11.3.1 Khondrion Company Detail
        11.3.2 Khondrion Business Overview
        11.3.3 Khondrion Mitochondrial Disease Therapeutics Introduction
        11.3.4 Khondrion Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.3.5 Khondrion Recent Development
    11.4 Stealth BioTherapeutics
        11.4.1 Stealth BioTherapeutics Company Detail
        11.4.2 Stealth BioTherapeutics Business Overview
        11.4.3 Stealth BioTherapeutics Mitochondrial Disease Therapeutics Introduction
        11.4.4 Stealth BioTherapeutics Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.4.5 Stealth BioTherapeutics Recent Development
    11.5 BioElectron Technology
        11.5.1 BioElectron Technology Company Detail
        11.5.2 BioElectron Technology Business Overview
        11.5.3 BioElectron Technology Mitochondrial Disease Therapeutics Introduction
        11.5.4 BioElectron Technology Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.5.5 BioElectron Technology Recent Development
    11.6 NeuroVive Pharmaceutical
        11.6.1 NeuroVive Pharmaceutical Company Detail
        11.6.2 NeuroVive Pharmaceutical Business Overview
        11.6.3 NeuroVive Pharmaceutical Mitochondrial Disease Therapeutics Introduction
        11.6.4 NeuroVive Pharmaceutical Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.6.5 NeuroVive Pharmaceutical Recent Development
    11.7 Mitobridge
        11.7.1 Mitobridge Company Detail
        11.7.2 Mitobridge Business Overview
        11.7.3 Mitobridge Mitochondrial Disease Therapeutics Introduction
        11.7.4 Mitobridge Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.7.5 Mitobridge Recent Development
    11.8 Mitochon Pharmaceuticals
        11.8.1 Mitochon Pharmaceuticals Company Detail
        11.8.2 Mitochon Pharmaceuticals Business Overview
        11.8.3 Mitochon Pharmaceuticals Mitochondrial Disease Therapeutics Introduction
        11.8.4 Mitochon Pharmaceuticals Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.8.5 Mitochon Pharmaceuticals Recent Development
    11.9 Mitocure
        11.9.1 Mitocure Company Detail
        11.9.2 Mitocure Business Overview
        11.9.3 Mitocure Mitochondrial Disease Therapeutics Introduction
        11.9.4 Mitocure Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.9.5 Mitocure Recent Development
    11.10 GenSight Biologics
        11.10.1 GenSight Biologics Company Detail
        11.10.2 GenSight Biologics Business Overview
        11.10.3 GenSight Biologics Mitochondrial Disease Therapeutics Introduction
        11.10.4 GenSight Biologics Revenue in Mitochondrial Disease Therapeutics Business (2019-2024)
        11.10.5 GenSight Biologics Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Mitochondrial Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Anti-Inflammatory Biologics
    Table 3. Key Players of Non-Steroidal Anti-Inflammatory Drugs
    Table 4. Key Players of Corticosteroids
    Table 5. Global Mitochondrial Disease Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Mitochondrial Disease Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Mitochondrial Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Mitochondrial Disease Therapeutics Market Share by Region (2019-2024)
    Table 9. Global Mitochondrial Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Mitochondrial Disease Therapeutics Market Share by Region (2025-2030)
    Table 11. Mitochondrial Disease Therapeutics Market Trends
    Table 12. Mitochondrial Disease Therapeutics Market Drivers
    Table 13. Mitochondrial Disease Therapeutics Market Challenges
    Table 14. Mitochondrial Disease Therapeutics Market Restraints
    Table 15. Global Mitochondrial Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Mitochondrial Disease Therapeutics Market Share by Players (2019-2024)
    Table 17. Global Top Mitochondrial Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitochondrial Disease Therapeutics as of 2023)
    Table 18. Ranking of Global Top Mitochondrial Disease Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Mitochondrial Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Mitochondrial Disease Therapeutics Product Solution and Service
    Table 22. Date of Enter into Mitochondrial Disease Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Mitochondrial Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Mitochondrial Disease Therapeutics Revenue Market Share by Type (2019-2024)
    Table 26. Global Mitochondrial Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Mitochondrial Disease Therapeutics Revenue Market Share by Type (2025-2030)
    Table 28. Global Mitochondrial Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Mitochondrial Disease Therapeutics Revenue Market Share by Application (2019-2024)
    Table 30. Global Mitochondrial Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Mitochondrial Disease Therapeutics Revenue Market Share by Application (2025-2030)
    Table 32. North America Mitochondrial Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Mitochondrial Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Mitochondrial Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Mitochondrial Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Mitochondrial Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Mitochondrial Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Mitochondrial Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Mitochondrial Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Mitochondrial Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Mitochondrial Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Mitochondrial Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Mitochondrial Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Mitochondrial Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Mitochondrial Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Mitochondrial Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Santhera Pharmaceuticals Company Detail
    Table 48. Santhera Pharmaceuticals Business Overview
    Table 49. Santhera Pharmaceuticals Mitochondrial Disease Therapeutics Product
    Table 50. Santhera Pharmaceuticals Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 51. Santhera Pharmaceuticals Recent Development
    Table 52. Reata Pharmaceuticals Company Detail
    Table 53. Reata Pharmaceuticals Business Overview
    Table 54. Reata Pharmaceuticals Mitochondrial Disease Therapeutics Product
    Table 55. Reata Pharmaceuticals Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 56. Reata Pharmaceuticals Recent Development
    Table 57. Khondrion Company Detail
    Table 58. Khondrion Business Overview
    Table 59. Khondrion Mitochondrial Disease Therapeutics Product
    Table 60. Khondrion Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 61. Khondrion Recent Development
    Table 62. Stealth BioTherapeutics Company Detail
    Table 63. Stealth BioTherapeutics Business Overview
    Table 64. Stealth BioTherapeutics Mitochondrial Disease Therapeutics Product
    Table 65. Stealth BioTherapeutics Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 66. Stealth BioTherapeutics Recent Development
    Table 67. BioElectron Technology Company Detail
    Table 68. BioElectron Technology Business Overview
    Table 69. BioElectron Technology Mitochondrial Disease Therapeutics Product
    Table 70. BioElectron Technology Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 71. BioElectron Technology Recent Development
    Table 72. NeuroVive Pharmaceutical Company Detail
    Table 73. NeuroVive Pharmaceutical Business Overview
    Table 74. NeuroVive Pharmaceutical Mitochondrial Disease Therapeutics Product
    Table 75. NeuroVive Pharmaceutical Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 76. NeuroVive Pharmaceutical Recent Development
    Table 77. Mitobridge Company Detail
    Table 78. Mitobridge Business Overview
    Table 79. Mitobridge Mitochondrial Disease Therapeutics Product
    Table 80. Mitobridge Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 81. Mitobridge Recent Development
    Table 82. Mitochon Pharmaceuticals Company Detail
    Table 83. Mitochon Pharmaceuticals Business Overview
    Table 84. Mitochon Pharmaceuticals Mitochondrial Disease Therapeutics Product
    Table 85. Mitochon Pharmaceuticals Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 86. Mitochon Pharmaceuticals Recent Development
    Table 87. Mitocure Company Detail
    Table 88. Mitocure Business Overview
    Table 89. Mitocure Mitochondrial Disease Therapeutics Product
    Table 90. Mitocure Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 91. Mitocure Recent Development
    Table 92. GenSight Biologics Company Detail
    Table 93. GenSight Biologics Business Overview
    Table 94. GenSight Biologics Mitochondrial Disease Therapeutics Product
    Table 95. GenSight Biologics Revenue in Mitochondrial Disease Therapeutics Business (2019-2024) & (US$ Million)
    Table 96. GenSight Biologics Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Mitochondrial Disease Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Mitochondrial Disease Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Anti-Inflammatory Biologics Features
    Figure 4. Non-Steroidal Anti-Inflammatory Drugs Features
    Figure 5. Corticosteroids Features
    Figure 6. Global Mitochondrial Disease Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Mitochondrial Disease Therapeutics Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Pharmacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Online Pharmacies Case Studies
    Figure 11. Mitochondrial Disease Therapeutics Report Years Considered
    Figure 12. Global Mitochondrial Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Mitochondrial Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Mitochondrial Disease Therapeutics Market Share by Region: 2023 VS 2030
    Figure 15. Global Mitochondrial Disease Therapeutics Market Share by Players in 2023
    Figure 16. Global Top Mitochondrial Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mitochondrial Disease Therapeutics as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Mitochondrial Disease Therapeutics Revenue in 2023
    Figure 18. North America Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Mitochondrial Disease Therapeutics Market Share by Country (2019-2030)
    Figure 20. United States Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Mitochondrial Disease Therapeutics Market Share by Country (2019-2030)
    Figure 24. Germany Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Mitochondrial Disease Therapeutics Market Share by Region (2019-2030)
    Figure 32. China Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Mitochondrial Disease Therapeutics Market Share by Country (2019-2030)
    Figure 40. Mexico Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Mitochondrial Disease Therapeutics Market Share by Country (2019-2030)
    Figure 44. Turkey Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Mitochondrial Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Santhera Pharmaceuticals Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 47. Reata Pharmaceuticals Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 48. Khondrion Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 49. Stealth BioTherapeutics Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 50. BioElectron Technology Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 51. NeuroVive Pharmaceutical Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 52. Mitobridge Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 53. Mitochon Pharmaceuticals Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 54. Mitocure Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 55. GenSight Biologics Revenue Growth Rate in Mitochondrial Disease Therapeutics Business (2019-2024)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed

Description

The global Mitochondrial Disease Therapeutics market was valued at US$ 390 million in 2023 and is anticipated to reach US$ 617.3 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.

North American market for Mitochondrial Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Mitochondrial Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mitochondrial Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Industry: Medical Care

Published: 2024-01-21

Pages: 89 Pages

Report ld: 2766546

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 2900.00

Multi Users License

USD 4350.00

Corporate Users License